Driven by experts,
led by science

Upperton Pharma Solutions is a Pharmaceutical Contract Development and Manufacturing Organisation (CDMO) with more than twenty years of experience in the development of pharmaceutical dosage forms.

We offer our clients an extensive range of services, from early feasibility to dosage form development and clinical trial manufacturing.

Driven by experts, led by science

We stand out as a CDMO offering unparalleled service. Our defining traits lie in our adaptability and nimbleness, allowing us to swiftly align with your evolving needs.

Your molecule reigns supreme. We pledge a commitment to prioritising your project, never relegating it to the bottom of a list.

Play Video

Expertise you can trust.

As a leading Contract, Development and Manufacturing Organisation (CDMO) our defining traits lie in our adaptability and nimbleness, enabling rapid product introduction.

Through a science-led approach we align to your drug development needs from pre-clinical to late phase commercial manufacture.

With more than 25 years of experience, count on us to navigate the complexities of your project with precision, expertise and our unique approach to project delivery.


Science-led delivery.

Supporting you from feasibility to market.

  • Formulation development

  • Phase 1 to Phase 3 clinical supply

  • Process scale-up and optimisation

  • Registration activities

  • Analytical development and validation

Our mission.

Passionate about science, we strive to build strong customer relationships and exceed their expectations.

We develop and manufacture high-quality drug products and share in our customers dedication to change the lives of patients.

Capability to meet your timeline.

Flexible and nimble, adapting to your project needs.

Our extensive expertise encompasses the development, scale-up, manufacturing, and rigorous testing of oral, pulmonary, and nasal drug products.

Our flexibility ensures that we can problem-solve, meet your timescales, and deliver solutions that meet patient targets.

Latest news

Work with a CDMO like no other.

Sign up to our insights